Pharmacological potential of cyclic nucleotide signaling in immunity

Pharmacol Ther. 2024 Jun:258:108653. doi: 10.1016/j.pharmthera.2024.108653. Epub 2024 Apr 26.

Abstract

Cyclic nucleotides are important signaling molecules that play many critical physiological roles including controlling cell fate and development, regulation of metabolic processes, and responding to changes in the environment. Cyclic nucleotides are also pivotal regulators in immune signaling, orchestrating intricate processes that maintain homeostasis and defend against pathogenic threats. This review provides a comprehensive examination of the pharmacological potential of cyclic nucleotide signaling pathways within the realm of immunity. Beginning with an overview of the fundamental roles of cAMP and cGMP as ubiquitous second messengers, this review delves into the complexities of their involvement in immune responses. Special attention is given to the challenges associated with modulating these signaling pathways for therapeutic purposes, emphasizing the necessity for achieving cell-type specificity to avert unintended consequences. A major focus of the review is on the recent paradigm-shifting discoveries regarding specialized cyclic nucleotide signals in the innate immune system, notably the cGAS-STING pathway. The significance of cyclic dinucleotides, exemplified by 2'3'-cGAMP, in controlling immune responses against pathogens and cancer, is explored. The evolutionarily conserved nature of cyclic dinucleotides as antiviral agents, spanning across diverse organisms, underscores their potential as targets for innovative immunotherapies. Findings from the last several years have revealed a striking diversity of novel bacterial cyclic nucleotide second messengers which are involved in antiviral responses. Knowledge of the existence and precise identity of these molecules coupled with accurate descriptions of their associated immune defense pathways will be essential to the future development of novel antibacterial therapeutic strategies. The insights presented herein may help researchers navigate the evolving landscape of immunopharmacology as it pertains to cyclic nucleotides and point toward new avenues or lines of thinking about development of therapeutics against the pathways they regulate.

Keywords: Adenylyl cyclase; Guanylyl cyclase; Innate immunity; Phage defense; STING; cGAS.

Publication types

  • Review

MeSH terms

  • Animals
  • Cyclic AMP / metabolism
  • Cyclic GMP / metabolism
  • Humans
  • Immunity, Innate
  • Membrane Proteins / metabolism
  • Neoplasms / drug therapy
  • Neoplasms / immunology
  • Nucleotides, Cyclic* / metabolism
  • Nucleotidyltransferases / metabolism
  • Signal Transduction*

Substances

  • Nucleotides, Cyclic
  • Cyclic AMP
  • Cyclic GMP
  • STING1 protein, human
  • Nucleotidyltransferases
  • Membrane Proteins